Forte Biosciences (FBRX) files $500M mixed shelf Jun 8, 2026 06:04AM
Forte Biosciences (FBRX) files $500M mixed shelf Jun 2, 2026 04:43PM
Forte Biosciences (FBRX) Misses Q1 EPS by 124c May 11, 2026 11:27AM
After-hours movers: Constellation Brands, Applied Digital, STAAR Surgical, New Era Energy & Digital Apr 8, 2026 04:31PM
Guggenheim on Forte Biosciences Inc. (FBRX): readout has 'highly favorable' risk/reward, set for +200% move Apr 2, 2026 10:19AM


Nov 25, 2025 06:49AM Evercore ISI Starts Forte Biosciences Inc. (FBRX) at Outperform
Nov 14, 2025 04:11PM Forte Biosciences (FBRX) Misses Q3 EPS by 99c
Aug 18, 2025 06:10AM Guggenheim Starts Forte Biosciences Inc. (FBRX) at Buy, PT $75
Aug 15, 2025 03:01PM Forte Biosciences Inc. (FBRX) PT Lowered to $54 at Brookline Capital Markets
Aug 14, 2025 05:42PM Forte Biosciences (FBRX) Misses Q2 EPS by 96c
Jun 24, 2025 04:01PM Forte Biosciences (FBRX) Announces Proposed Share Offering
Jun 23, 2025 07:19AM Forte Biosciences (FBRX) Announces Positive Data in FB102 Celiac Disease Phase 1B Study
May 15, 2025 06:53PM Forte Biosciences (FBRX) Misses Q1 EPS by 137c
Mar 28, 2025 04:46PM Forte Biosciences (FBRX) Files $300M Mixed Shelf
Jan 21, 2025 05:33AM TD Cowen Starts Forte Biosciences Inc. (FBRX) at Buy
Nov 20, 2024 09:19AM Forte Biosciences (FBRX) Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
Nov 15, 2024 06:18AM Forte Biosciences (FBRX) Misses Q3 EPS by 433c